QuickView for adenosine A2B receptor;jsessionid=C9244157A47D83BCAA6073C131E713B4;jsessionid=88BC444664888E06EF607A65B6482339 (gene)

1. The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer.
2. Irreversible Antagonists for the Adenosine A2B Receptor.
3. A patent review of adenosine A2B receptor antagonists (2016-present).
4. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway.
5. CD73-Dependent Adenosine Signaling through Adora2b Drives Immunosuppression in Ductal Pancreatic Can…

There were no clinical trials for adenosine A2B receptor;jsessionid=C9244157A47D83BCAA6073C131E713B4;jsessionid=88BC444664888E06EF607A65B6482339